Work

Evaluating the safety of abiraterone acetate (AA) and docetaxel (D) administered in combination in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC).

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.4_suppl.205

Authors: Scott T. Tagawa, David M. Nanus, Edwin M. Posadas, Daniel Peter Petrylak, Justine Yang Bruce, Emerson A. Lim, Weimin Peng, Raymond Scott Maul, Martha Gonzalez, Namphuong Tran

Institutions: Weill Cornell Medicine, Cedars-Sinai Medical Center, Yale Cancer Center, University of Wisconsin–Madison, Columbia University Irving Medical Center, Janssen Research & Development (United States)

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590551674

Cites:

Cited by: 1

Related to: 10